WallStSmart

CareCloud Inc. (CCLD)vsMiniMed Group, Inc. Common Stock (MMED)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

MiniMed Group, Inc. Common Stock generates 2295% more annual revenue ($2.89B vs $120.50M). CCLD leads profitability with a 9.0% profit margin vs -7.3%. CCLD earns a higher WallStSmart Score of 54/100 (C-).

CCLD

Buy

54

out of 100

Grade: C-

Growth: 6.7Profit: 7.0Value: 8.3Quality: 7.0
Piotroski: 5/9Altman Z: 2.36

MMED

Hold

37

out of 100

Grade: F

Growth: 5.3Profit: 3.5Value: 5.0Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CCLDUndervalued (+52.1%)

Margin of Safety

+52.1%

Fair Value

$4.68

Current Price

$3.50

$1.18 discount

UndervaluedFair: $4.68Overvalued

Intrinsic value data unavailable for MMED.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CCLD4 strengths · Avg: 8.8/10
EPS GrowthGrowth
57.4%10/10

Earnings expanding 57.4% YoY

Debt/EquityHealth
0.179/10

Conservative balance sheet, low leverage

Price/BookValuation
2.5x8/10

Reasonable price relative to book value

Revenue GrowthGrowth
21.9%8/10

Revenue surging 21.9% year-over-year

MMED0 strengths · Avg: 0/10

No standout strengths identified

Areas to Watch

CCLD2 concerns · Avg: 3.5/10
P/E RatioValuation
34.3x4/10

Premium valuation, high expectations priced in

Market CapQuality
$145.75M3/10

Smaller company, higher risk/reward

MMED4 concerns · Avg: 3.0/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Return on EquityProfitability
0.0%3/10

ROE of 0.0% — below average capital efficiency

Operating MarginProfitability
1.4%3/10

Operating margin of 1.4%

Free Cash FlowQuality
$-53.00M2/10

Negative free cash flow — burning cash

Comparative Analysis Report

WallStSmart Research

Bull Case : CCLD

The strongest argument for CCLD centers on EPS Growth, Debt/Equity, Price/Book. Revenue growth of 21.9% demonstrates continued momentum.

Bull Case : MMED

Revenue growth of 13.1% demonstrates continued momentum.

Bear Case : CCLD

The primary concerns for CCLD are P/E Ratio, Market Cap.

Bear Case : MMED

The primary concerns for MMED are EPS Growth, Return on Equity, Operating Margin.

Key Dynamics to Monitor

CCLD profiles as a growth stock while MMED is a turnaround play — different risk/reward profiles.

CCLD is growing revenue faster at 21.9% — sustainability is the question.

CCLD generates stronger free cash flow (6M), providing more financial flexibility.

Monitor HEALTH INFORMATION SERVICES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

CCLD scores higher overall (54/100 vs 37/100) and 21.9% revenue growth. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

CareCloud Inc.

HEALTHCARE · HEALTH INFORMATION SERVICES · USA

CareCloud, Inc., a healthcare information technology (IT) company, provides a suite of cloud-based solutions and related business services to healthcare providers and hospitals primarily in the United States. The company is headquartered in Somerset, New Jersey.

Visit Website →

MiniMed Group, Inc. Common Stock

HEALTHCARE · HEALTH INFORMATION SERVICES · USA

Minimed Group, Inc. is a medical technology company that develops, manufactures, and markets medical equipment for the management of diabetes. The company is headquartered in Northridge, California.

Want to dig deeper into these stocks?